Navigation Links
A much-needed shot in the arm for HIV vaccine development

International efforts towards developing a vaccine against HIV infection have been given a much-needed boost by the publication today of the Global HIV/AIDS Vaccine Enterprise's scientific strategic plan, published online in the freely available, open-access global health journal PLoS Medicine. The Global HIV/AIDS Vaccine Enterprise is an international alliance of independent agencies and organizations conducting or supporting HIV vaccine research. In June 2004, the G8 countries endorsed its goals, and will consider the new plan at its forthcoming summit meeting in the United Kingdom this July.

The coordinating committee of the plan reads like a "who's who" of global AIDS experts, including Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; Peter Piot, Executive Director of UNAIDS; and Pascoal Mocumbi, former Prime Minister of Mozambique and Representative of the European Developing Country Clinical Trials Partnership. The Enterprise partners include many of the world's top AIDS vaccine funding and advocacy organizations, including the Bill & Melinda Gates Foundation, the US National Institutes of Health, the International AIDS Vaccine Initiative, the World Health Organization, UNAIDS, and the AIDS Vaccines Advocacy Coalition. The plan, developed with the collaboration of over 140 scientists worldwide, identifies the major scientific roadblocks facing HIV vaccine development, outlines a strategic approach to addressing them, and proposes an innovative collaborative model that ensures that researchers across the globe are harnessing their efforts towards a common goal. "Development of an HIV vaccine remains one of the most difficult challenges confronting biomedical research today," write the plan's authors, but fortunately "scientific progress has created new opportunities that could be harnessed more effectively through global coordination and collaboration." "These new opportunit
'"/>

Source:PLoS Medicine


Page: 1 2 3

Related biology news :

1. Research advances quest for HIV-1 vaccine
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. Gene vaccine for Alzheimers disease shows promising results
4. Influenza vaccine uses insect cells to speed development
5. Norovirus, AIDS vaccine and Hepatitis Virus
6. HIV vaccine trial breaks ground for future research
7. Live vaccines more effective against horse herpes virus
8. NIAID begins clinical trial of West Nile virus vaccine
9. Designing vaccines by computer
10. Wake Forest scientists find new combination vaccine effective against plague
11. New vaccine means bye-bye to bacteria in the lung
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: much needed shot the arm for HIV vaccine development

(Date:4/17/2014)... study suggests that fish consumption advisories for expecting ... long-lived contaminants like persistent organic pollutants (POPs). ... researchers including University of Toronto Scarborough PhD student ... how different levels of environmental contamination, a mother,s ... in the body influenced exposure in her children. ...
(Date:4/17/2014)... credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories ... safer, easier, faster and cheaper. , Bacillus ... found in soils all over the world and can ... and animals. The bacteria can survive in harsh conditions ... may occur through skin contact, inhalation of spores ...
(Date:4/17/2014)... in German . ... they also provide us with a continuous stream of information ... or sit still in a car the world glides ... retinas. Seemingly without effort, our brain calculates self-motion from this ... and a steady gaze during our own movements. Together with ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4
... to avoid smiling in public in order to hide their ... costly treatment options, such as veneers, crowns and bonding, served ... such stains and boost their self-esteem. , However, Kim ... how a new tooth whitening procedure he used on a ...
... women, accumulated sun exposure has already permanently damaged their ... up as unsightly dark splotches and uneven skin tone ... a compound best known for treating arthritis ?can actually ... help fade existing ones. , "These findings on glucosamine ...
... In a paper being presented in two American ... joint Estonian-French team demonstrated "for the first time ... suggesting that mitochondria may mechanically regulate nuclear function." ... over 10 years, reported that it recently "found ...
Cached Biology News:Tetracycline plus teeth equal gray smile 2Tetracycline plus teeth equal gray smile 3Science finds new fix for UV-damaged skin in arthritis treatment 2Science finds new fix for UV-damaged skin in arthritis treatment 3First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 2First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 3
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal ... been selected by Buffalo BioBlower Technologies LLC ("B3") as ... SBIR Phase 2 award from the Army Corps of ... system that kills all biological contaminants and destroys VOCs ...
(Date:1/15/2014)... and SAN JOSE, California , January ... company developing antibody-drug conjugates for cancer, today announced the appointment ... Directors. Dr Reynolds has over 20 years, development experience gained ... at Seattle Genetics. "I am delighted to welcome ...
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), today announced ... at 9:00 a.m. Eastern Time on Thursday,November 15, 2007 ... Flavin, Ph.D., Chairman & Chief Executive Officer, and other,members ... on the Company.,A press release reporting the third quarter ...
... Genasense Plus Temodar(R) and Abraxane(R) Show Promising Early Clinical ... ... Activity, BERKELEY HEIGHTS, N.J., Nov. 8 Genta,Incorporated (Nasdaq: ... the Company,s lead oncology drug, Genasense(R) (oblimersen,sodium) Injection in combination ...
... Inc.,(Nasdaq: MEDX ) today announced that Marc Rubin, ... to serve as a director on Medarex,s Board,effective November ... of Titan Pharmaceutical, Inc., a,biopharmaceutical company publicly traded on ... 2007, he was Head of Global Research and,Development for ...
Cached Biology Technology:Advanced Life Sciences to Host Third Quarter 2007 Financial Results Conference Call and Live Webcast 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 3Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 4Medarex Announces Election of Marc Rubin as New Board Member 2
...
... Hormone Receptor 2 ( Abpromise ... Antigen: Synthetic peptide: AFRHCNPNGTWDFMHSLN, ... of Human Parathyroid Hormone Receptor 2 ... 5746 Swiss ...
... pan B (B220), 4.5 m, coated ... efficient positive isolation or depletion of ... or lymph node cell suspensions. B220 ... cells and lytically active subsets of ...
POU domain, class 2, transcription factor 2,...
Biology Products: